Presentation of information about drug approval and level of warning
OtherPresentation of information about date of drug approval with no new drug warning, a non-directive drug box warning or a directive drug box warning
NCT Number: NCT00950131
The purpose of this study is to test whether a new drug warning decreases enthusiasm for new drugs.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Presentation of information about date of drug approval with no new drug warning, a non-directive drug box warning or a directive drug box warning
Time frame: 0 weeks (assessed during intervention)
Time frame: 0 weeks (assessed during intervention)
White River Junction Veterans Affairs Medical Center
Fed
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00950157
Risk Communication
View Trial DetailsNCT00950014
Risk Communication
View Trial DetailsNCT06856694
Behavior, Communication
Los Angeles, California, United States
View Trial Details